Skip to Main Content
Pharmacist's Letter
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • Natural Medicines
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • COVID-19 Resources
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
    • Journal Club
  • Podcasts
  • New Drugs
    • New Drugs
    • First Time Generics
  • Help
    • User Support
    • Contact Us
  • Go To CE/CME & Training

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

  1. Home
  2. Browse
  3. Diabetes & Endocrinology
  4. Diabetes

Diabetes

  • Diabetes (729)
    • Blood Glucose Meters (7)
    • Complications (199)
    • Diabetes in Pregnancy (11)
    • Diabetes Meds (79)
    • Drug-Induced Hypo/Hyperglycemia (138)
    • Monitoring (134)
    • Natural Medicines/Supplements (9)
    • Prevention (47)
    • Treatment (364)
  • Endocrinology (8)
  • Hyperglycemia (38)
  • Hypoglycemia (19)
  • Other (31)
  • Prediabetes (5)
  • Resources (276)
  • Thyroid Disorders (53)
361 - 375 of 729 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Chart: Aspirin Dose for Cardiovascular Indications September 2013
Article: Nesina (nes-SEE-na, alogliptin) will compete in a crowded market of gliptins, or DPP-4 inhibitors, for type 2 diabetes August 2013
Commentary: V-Go Insulin Delivery Device August 2013
Article: The rosiglitazone (Avandia, etc) saga isn't quite over July 2013
PL Voices: New Drug Options for Weight Loss July 2013
Article: Belviq (bel-VEEK, lorcaserin) will join Qsymia and other weight loss meds in the battle of the bulge July 2013
Article: more opportunities to help manage gastroparesis June 2013
Patient Education: Tips for Getting to a Healthy Weight June 2013
Commentary: Pharmacotherapy of Gastroparesis June 2013
PL Voices: Prevention and Treatment of Hypoglycemia June 2013
Guideline: Management of Gastroparesis (2013) June 2013
Guideline: Hypoglycemia and Diabetes: a Report of a Workgroup of the American Diabetes Association and the Endocrine Society (2013) June 2013
Article: more emphasis on preventing and treating hypoglycemia in patients with type 2 diabetes June 2013
Article: Invokana (in-vo-KAHN-uh, canagliflozin), the first in a new class of oral drugs for type 2 diabetes May 2013
Commentary: New Drug: Invokana (Canagliflozin) May 2013
  • « Prev
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Testimonials
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved